Home/Teikoku Pharma/Misako Fujioka
MF

Misako Fujioka

President and CEO

Teikoku Pharma

Roles

President and CEOatTeikoku Pharma
President and CEOatTeikoku Seiyaku

Teikoku Pharma Pipeline

DrugIndicationPhase
Lidoderm® / Versatis®PHN (Post-Herpetic Neuralgia)Market
Docetaxel Alcohol-free InjectionSolid TumorsMarket
TPU-006Post-Surgical Pain ManagementPhase 2
TPU-030Agitation Associated with Dementia of the Alzheimer’s TypePhase 2
TK-254RxAcute Minor Sport InjuryPhase 2